Real-Time EHR Write-Back Speech Biomarker Screening
Key Facts
- GIA screens for 46 conditions (21 live, 25 coming soon) using 2,500+ speech biomarkers.
- Screening results are available in approximately 60 seconds and are written directly back to the EHR.
- GIA integrates with major EHR systems including Epic, Cerner, PointClickCare, MatrixCare, and American HealthTech.
- GIA is 510(k) registered and HIPAA compliant, ensuring patient data security and privacy.
- GIA speaks 92 languages, facilitating broader access to screening.
Clinicians need time back in their day. Our [real time EHR write back speech biomarker screening] simplifies documentation. By integrating directly with leading EHR systems, including Epic, Cerner, PointClickCare, MatrixCare, and American HealthTech, GIA eliminates dual documentation. The screening process is quick, results are available in 60 seconds, and the findings are automatically written back to the patient's chart while the patient is still present. This saves valuable time and reduces the risk of errors associated with manual data entry.
The Challenge of Traditional Clinical Screening and EHR Documentation
Traditional clinical screening methods often involve manual processes, from administering questionnaires to documenting results. This can be particularly challenging in busy clinical settings, leading to delays in diagnosis and treatment. The current documentation process often requires clinicians to manually enter screening data into the EHR system, creating a dual documentation burden. This not only consumes valuable time but also increases the risk of errors. With an aging population and the increasing prevalence of conditions like cognitive decline (where our screening shows 70.8% accuracy) and depression (81.6% accuracy), the need for more efficient screening and documentation methods is greater than ever. The manual nature of these processes can also lead to inconsistencies in data, making it difficult to track patient progress and make informed decisions. This is further complicated by the fact that conditions like mild cognitive impairment (MCI) affect an estimated 12 million Americans, with 92% unaware of their condition. GIA offers a approach to simplify this process, ensuring accurate and timely documentation without adding to the administrative burden on clinical staff. Perhaps a clinical deployment program is in order to demonstrate the time savings and accuracy improvements.
How Speech Biomarker Screening Works with EHR Integration
GIA uses the power of speech biomarkers to screen for a range of conditions. Our system analyzes speech patterns to identify subtle indicators of underlying health issues. This screening process is non-invasive, quick, and can be administered in various settings. The key advancement lies in the integration with EHR systems. Once a screening is complete, the results are automatically written back to the patient's EHR. This [automated EHR documentation screening] eliminates the need for manual data entry, saving clinicians time and reducing the risk of errors. The screening process itself is designed to be user-friendly, allowing healthcare professionals to administer it with minimal training. GIA speaks 92 languages, allowing clinicians to work with a more diverse population. Furthermore, GIA can administer Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) assessments, with results written back to the EHR. This provides a complete view of the patient's functional abilities, aiding in care planning and management.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
Benefits of Real-Time EHR Write-Back for Clinical clinical processes
The benefits of [real time EHR write back speech biomarker screening] are multifaceted. First and foremost, it saves clinicians valuable time. By automating the documentation process, clinicians can spend more time focusing on patient care. Secondly, it reduces the risk of errors associated with manual data entry. The automated write-back process ensures that the screening results are accurately recorded in the EHR. Thirdly, it improves the efficiency of clinical clinical processes. With screening results readily available in the EHR, clinicians can make informed decisions more quickly. GIA also facilitates better communication and collaboration among healthcare providers. The integrated data provides a whole-person view of the patient's health status, enabling more coordinated care. For example, the GIA screening for Parkinson's disease has an AUC of 0.97, giving clinicians valuable information. Finally, this also helps facilities stay compliant with CMS F-Tag 758, as it pertains to behavioral health screenings.
Supported EHR Systems and Implementation
GIA is designed to integrate with a wide range of EHR systems, including Epic, Cerner, PointClickCare, MatrixCare, and American HealthTech. This ensures that healthcare providers can directly incorporate GIA into their existing clinical processes. The implementation process is straightforward, with support provided to ensure a smooth transition. Our team works closely with healthcare organizations to configure the system and train staff on its use. We also offer ongoing support to address any questions or concerns. The integration with these EHR systems allows for a streamlined flow of information, enabling clinicians to access screening results directly from the patient's chart. This eliminates the need to switch between different systems, saving time and improving efficiency. Furthermore, the integration ensures that the screening data is securely stored within the EHR, maintaining patient privacy and confidentiality. GIA is HIPAA compliant and 510(k) registered, providing assurance of data security and regulatory compliance. A demo can show you how easily GIA integrates into your current EHR.
Accuracy and Validation of Speech Biomarker Technology
The accuracy of our speech biomarker technology is paramount. Our screening algorithms have been rigorously tested and validated to ensure reliable results. For example, our screening demonstrates 81.6% accuracy for depression, 80.0% for PTSD, and 77.5% for anxiety. These figures reflect the performance of our system in identifying these conditions based on speech patterns. It's important to note that GIA is a screening tool and does not provide diagnoses. A human-in-the-loop approach is always maintained, with clinicians reviewing the screening results and making informed decisions based on their clinical judgment. The speech analysis incorporates over 2,500 speech biomarkers to provide a complete picture. GIA is also designed to be culturally sensitive, accounting for variations in speech patterns across different languages and dialects. The system is continuously updated and improved based on ongoing research and clinical feedback. GIA uses Samsung Health Grade Galaxy devices with Samsung Knox for secure data collection and transmission.
Reimbursement and CPT Codes
The [clinical screening EHR integration] offered by GIA can be supported by existing reimbursement structures. Several CPT codes are applicable to the administration and interpretation of cognitive and behavioral assessments. These include CPT code 96127, which typically reimburses between $6 and $10, CPT code 96116, which reimburses between $94 and $131, and CPT code 99309, which reimburses around $100. These codes can be used to bill for the time and resources involved in administering and interpreting the screening results. It's important to note that reimbursement rates may vary depending on the payer and the specific services provided. Healthcare providers should consult with their billing departments and payers to ensure accurate coding and reimbursement. The cost-effectiveness of GIA is further enhanced by the time savings and efficiency gains it provides. By automating the documentation process and improving clinical clinical processes, GIA can help healthcare organizations reduce administrative costs and improve their bottom line. Contact us to explore the financial benefits of implementing GIA.
Conclusion
Real-time EHR write-back is here. By automating the documentation process and integrating directly with leading EHR systems, GIA saves clinicians valuable time, reduces the risk of errors, and improves the efficiency of clinical clinical processes. With accuracy rates up to 81.6% for depression and an AUC of 0.97 for Parkinson's, GIA provides valuable screening information to support clinical decision-making, after clinician review. It is a 510(k) registered and HIPAA compliant platform that enhances patient care and simplifies administrative tasks. If you're looking to improve your clinical clinical processes and patient outcomes, we invite you to request a demo to see how GIA can benefit your organization. GIA speaks 92 languages and can be deployed across various healthcare settings.
Sources & References
- Centers for Medicare & Medicaid Services (CMS). Quality measures and star ratings. cms.gov
- Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
- Scienza Health clinical validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
- U.S. Food & Drug Administration. 510(k) device registration database. fda.gov
David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) registered, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.
Frequently Asked Questions
Does GIA provide a diagnosis?
No, GIA screens and does not provide diagnoses. She assists healthcare professionals in identifying potential health issues based on speech patterns. The screening results are intended to be used in conjunction with other clinical information to make informed decisions. A human-in-the-loop approach is always maintained, with clinicians reviewing the screening results and making diagnoses based on their professional judgment, before results are added to the clinical record.
How long does a screening take?
A screening with GIA typically takes under 5 minutes to administer. The results are available in 60 seconds. This makes it a quick and efficient way to screen for a variety of conditions. The speed of the screening process allows healthcare professionals to screen more patients in a shorter amount of time, improving efficiency and throughput. GIA can be easily integrated into existing clinical clinical processes, minimizing disruption and maximizing productivity.
Is GIA HIPAA compliant?
Yes, GIA is HIPAA compliant. We take patient privacy and data security very seriously. Our system is designed to protect sensitive patient information and comply with all applicable regulations. We use Samsung Health Grade Galaxy devices with Samsung Knox for secure data collection and transmission. We also have strong security measures in place to prevent unauthorized access to patient data. Our commitment to HIPAA compliance ensures that healthcare providers can use GIA with confidence, knowing that their patients' privacy is protected.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.